Neonatal alloimmune thrombocytopenia due to a new platelet-specific alloantibody.
An infant with severe neonatal alloimmune thrombocytopenia is described in whom an antibody directed at a new platelet-specific alloantigen, Ca (HPA-6b), is implicated. The new alloantigen is of low frequency in the population and was localized to platelet glycoprotein (GP) IIIa. Immunoprecipitation studies using murine monoclonal antibodies specific for the GP complex IIb-IIIa and GPIIIa alone (AP2 and AP3) suggest that the location of the Ca epitope on GPIIIa may be near the binding site for AP3. Neonatal alloimmune thrombocytopenia associated with Ca is likely to be as severe as that seen in cases due to incompatibilities for the HPA-1 (PIA) and HPA-4 (Pen) platelet alloantigen systems, because each is located on GPIIIa, a densely represented molecule on the platelet surface.
McFarland
J G
JG
Blood Center of Southeastern Wisconsin, Milwaukee 53233.
Blanchette
V
V
Collins
J
J
Newman
P J
PJ
Wang
R
R
Aster
R H
RH
D016824:Antigens, Human Platelet / Q000032:analysis / Q000235:genetics / Q000276:immunology*; D001792:Blood Platelets / Q000276:immunology; D004200:Diseases in Twins; D005260:Female; D006801:Humans; D016130:Immunophenotyping; D007231:Infant, Newborn; D007518:Isoantibodies / Q000276:immunology*; D008297:Male; D010375:Pedigree; D010980:Platelet Membrane Glycoproteins / Q000276:immunology; D013921:Thrombocytopenia / Q000276:immunology*
D016824:Antigens, Human Platelet; D007518:Isoantibodies; D010980:Platelet Membrane Glycoproteins